Iovance Biotherapeutics, Inc. ( IOVA) - Stock Earnings
IOVA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
IOVA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -71.9 million USD | 86.8 million USD |
| 2026Q1 | -79.0 million USD | 71.4 million USD |
| 2026Q2 | -47.3 million USD | 99.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IOVA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -444.0 million USD | 1.2 million USD |
| 2024 | -372.2 million USD | 164.1 million USD |
| 2025 | -391.0 million USD | 263.5 million USD |
| 2026 Est. | — | — |
IOVA
Price: $14.21
52 week price:
Earnings Per Share: -0.69 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.5 million
Ebitda: -22.1 millionMarket Capitalization: 5.7 billion